scholarly journals Generation and administration of HA-1-specific T-cell lines for the treatment of patients with relapsed leukemia after allogeneic stem cell transplantation: a pilot study

Haematologica ◽  
2012 ◽  
Vol 97 (8) ◽  
pp. 1205-1208 ◽  
Author(s):  
P. Meij ◽  
I. Jedema ◽  
M. A. W. G. van der Hoorn ◽  
R. Bongaerts ◽  
L. Cox ◽  
...  
Keyword(s):  
Stem Cell ◽  
T Cell ◽  
Pilot Study ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Cell Lines ◽  
Allogeneic Stem Cell Transplantation ◽  
T Cell Lines

Effective Treatment of Refractory CMV Reactivation After Allogeneic Stem Cell Transplantation With In Vitro-generated CMV pp65-specific CD8+ T-cell Lines

2012 ◽  
Vol 35 (8) ◽  
pp. 621-628 ◽  
Author(s):  
Pauline Meij ◽  
Inge Jedema ◽  
Maarten L. Zandvliet ◽  
Pim L. J. van der Heiden ◽  
Marian van de Meent ◽  
...  
Keyword(s):  
Stem Cell ◽  
T Cell ◽  
Stem Cell Transplantation ◽  
Effective Treatment ◽  
Cell Lines ◽  
Allogeneic Stem Cell Transplantation ◽  
Cd8 T Cell ◽  
T Cell Lines ◽  
Cmv Reactivation

scholarly journals Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients

Cancer Cell ◽  
2021 ◽  
Vol 39 (12) ◽  
pp. 1654
Author(s):  
Patrick Harrington ◽  
Katie J. Doores ◽  
Chandan Saha ◽  
Jamie Saunders ◽  
Fiona Child ◽  
...  
Keyword(s):  
Stem Cell ◽  
T Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Allogeneic Stem Cell Transplantation ◽  
Cell Response ◽  
T Cell Response

Impact of cyclosporine-A concentration in T-cell replete haploidentical allogeneic stem cell transplantation

2018 ◽  
Vol 32 (4) ◽  
pp. e13220 ◽  
Author(s):  
Xiaofei Yang ◽  
Shuo Yang ◽  
Aining Sun ◽  
Huiying Qiu ◽  
Xiaowen Tang ◽  
...  
Keyword(s):  
Stem Cell ◽  
T Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Cyclosporine A ◽  
Allogeneic Stem Cell Transplantation

What is the future of immunotherapy in multiple myeloma?

Blood ◽  
2020 ◽  
Vol 136 (22) ◽  
pp. 2491-2497
Author(s):  
Leo Rasche ◽  
Michael Hudecek ◽  
Hermann Einsele
Keyword(s):  
Multiple Myeloma ◽  
Monoclonal Antibodies ◽  
Stem Cell ◽  
T Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Allogeneic Stem Cell Transplantation ◽  
Cell Therapies ◽  
The Future

Abstract The treatment of multiple myeloma (MM) is currently being redefined by humoral and cellular immunotherapies. For decades, there was limited belief in immune-based anti-MM therapy as a result of the moderate graft-versus-myeloma effect of allogeneic stem cell transplantation. Today, monoclonal antibodies comprise the new backbone of anti-MM therapy, and T-cell therapies targeting BCMA are emerging as the most potent single agents for MM treatment. Herein, we present our assessment of and vision for MM immunotherapy in the short and midterm.

scholarly journals T cell regeneration in pediatric allogeneic stem cell transplantation

2007 ◽  
Vol 39 (3) ◽  
pp. 149-156 ◽  
Author(s):  
H Olkinuora ◽  
K Talvensaari ◽  
T Kaartinen ◽  
S Siitonen ◽  
U Saarinen-Pihkala ◽  
...  
Keyword(s):  
Stem Cell ◽  
T Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Allogeneic Stem Cell Transplantation ◽  
Cell Regeneration

Allogeneic stem cell transplantation for hepatosplenic gammadelta T-cell lymphoma

2007 ◽  
Vol 48 (3) ◽  
pp. 630-632 ◽  
Author(s):  
Takaaki Konuma ◽  
Jun Ooi ◽  
Satoshi Takahashi ◽  
Akira Tomonari ◽  
Nobuhiro Tsukada ◽  
...  
Keyword(s):  
Stem Cell ◽  
T Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Allogeneic Stem Cell Transplantation ◽  
Cell Lymphoma ◽  
T Cell Lymphoma
Sign in / Sign up

Export Citation Format

Share Document